Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fonc.2021.675038 http://scihub22266oqcxt.onion/10.3389/fonc.2021.675038 34079764!8165307!34079764     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Oncol 2021 ; 11 (ä): 675038 Nephropedia Template TP {{tp|p=34079764|t=2021. Has COVID-19 Affected Cancer Screening Programs? A Systematic Review |pdf=|usr=}}{{34079764}} gab.com Text Has COVID-19 Affected Cancer Screening Programs A Systematic Review JO: Front Oncol http://www.kidney.de/pget.php?&tw=1&pmid=34079764 #FOAvip BACKGROUND: Health care services across the world have been enormously affected by the onset of the coronavirus disease 2019 (COVID-19). Services in oncology have been curtailed because medical services have been focused on preventing the spread of the virus and maximizing the number of available hospital beds. The present study was designed to investigate the impact of COVID-19 on cancer screening. METHODS: Databases such as Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan) and Scopus were searched comprehensively for articles published until January 2021. The keywords used were COVID-19 and cancer screening, Articles dealing with cancer screening in the COVID-19 pandemic were included in the review. RESULTS: The review comprised 17 publications. The impact of COVID-19 was categorized into four dimensions: a significant decline in cancer screening and pathology samples, the cancer diagnosis rate, an increase in advanced cancers, mortality rate and years of life lost (YLLs). CONCLUSION: Cancer screening programs have been clearly interrupted since the onset of the COVID-19 disease. The anticipated outcomes include delayed diagnosis and marked increases in the numbers of avoidable cancer deaths. Urgent policy interventions are needed to handle the backlog of routine diagnostic services and minimize the harmful effects of the COVID-19 pandemic on cancer patients. Twit Text FOAVip Has COVID-19 Affected Cancer Screening Programs A Systematic Review ????Front Oncol http://www.kidney.de/pget.php?&tw=1&pmid=34079764 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34079764 #FOAvip English Wikipedia <ref>{{Cite pmid|34079764}}</ref> Has COVID-19 Affected Cancer Screening Programs? A Systematic Review #MMPMID34079764 Alkatout I; Biebl M; Momenimovahed Z; Giovannucci E; Hadavandsiri F; Salehiniya H; Allahqoli L Front Oncol 2021[]; 11 (ä): 675038 PMID34079764show ga BACKGROUND: Health care services across the world have been enormously affected by the onset of the coronavirus disease 2019 (COVID-19). Services in oncology have been curtailed because medical services have been focused on preventing the spread of the virus and maximizing the number of available hospital beds. The present study was designed to investigate the impact of COVID-19 on cancer screening. METHODS: Databases such as Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan) and Scopus were searched comprehensively for articles published until January 2021. The keywords used were COVID-19 and cancer screening, Articles dealing with cancer screening in the COVID-19 pandemic were included in the review. RESULTS: The review comprised 17 publications. The impact of COVID-19 was categorized into four dimensions: a significant decline in cancer screening and pathology samples, the cancer diagnosis rate, an increase in advanced cancers, mortality rate and years of life lost (YLLs). CONCLUSION: Cancer screening programs have been clearly interrupted since the onset of the COVID-19 disease. The anticipated outcomes include delayed diagnosis and marked increases in the numbers of avoidable cancer deaths. Urgent policy interventions are needed to handle the backlog of routine diagnostic services and minimize the harmful effects of the COVID-19 pandemic on cancer patients. äHas COVID-19 Affected Cancer Screening Programs? A Systematic Review (epmc).pdf DeepDyve Pubget Overpricing